the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences
Japanese Korean Chinese

Market Research Report

Generic Series: Optimizing Brand Lifecycle Management Winning Strategies to Maximize Revenue in the Face of Growing Generic Competition

Published by Datamonitor Contact us : +1-860-674-8796
Published 2008/07 Content info  
Product code DC74909
Price From  US $ 7600 Order/Price list
US $ 7600 PDF by E-mail (Single User License)
US $ 19000 PDF by E-mail (Global License)
Delivery Time
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Description TOC

Abstract

Overview

Introduction

As competitive pressures from the entry of generics post-patent expiry and new brands are growing, product lifecycles are evolving for the worst. Effective lifecycle management is becoming a must for Pharma looking to maximize their return on investment, regardless of which stage of the lifecycle a drugs is in. However such strategies are becoming most prominent immediately before patent expiry.

Scope

  • Review of key reasons why lifecycle management is important now
  • Analysis of key considerations Pharma need to take care of when devising lifecycle management strategies
  • Discussion of most commonly used lifecycle management strategies
  • Case study analysis of successful and unsuccessful lifecycle management strategies employed by Pharma

Highlights

One of the key challenges for Pharma is the loss of corporate memory regarding specific brands as brand managers spend on average only 18 months on one product with mainly short term goals in mind. Pharma need to take a structured approach to lifecycle management with a regular review of their strategies in response to internal and external events.

Lifecycle management should not be left until only few years are left to patent expiry. Revenues can be maximized during launch and peak phases by employing the right approaches. If a company starts planning its lifecycle management strategy early, it has more strategies available. However, many companies leave planning until late in the lifecycle.

Payers and physicians are becoming more sceptical of certain steps taken by Pharma as they consider them to be pure lifecycle management. Follow-on products such as reformulations and fixed dose combinations need to ensure they truly satisfy an unmet need in order to achieve even moderate uptake.

Reasons to Purchase

  • Identify critical considerations for creating the optimal lifecycle management plan
  • Understand when the different lifecycle management strategies are most appropriate
  • Gain insight into recent successful and unsuccessful lifecycle management strategies
Related Report
Back to Top
Please inform me when related publications are released
InfoWatch

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.